Newsroom
Sorted by: Latest
-
Leading AI Investor Menlo Ventures Invests in Factory
SAN FRANCISCO--(BUSINESS WIRE)--Factory, the global leader in self-improving software development, announced today that Menlo Ventures has invested in the company, led by Matt Murphy, Managing Partner. Murphy has spent more than two decades investing through major shifts in enterprise technology and has emerged as a leading investor in the AI era. At the outset of the generative AI transformation, he led Menlo’s pre-product investment in Anthropic and has since backed companies reshaping the AI...
-
WilliamsMarston Welcomes Dave Minker as Chief Information Officer
BOSTON--(BUSINESS WIRE)--WilliamsMarston, a national leader in accounting, tax, technology, transaction and valuation advisory services, announced Dave Minker has joined the firm as Chief Information Officer (CIO). Based in Boston, Minker will lead WilliamsMarston’s overall technology strategy and IT operations, building on the firm’s existing capabilities to support its continued growth. Minker brings more than 25 years of technology and transformation experience spanning professional services...
-
TIAA-CREF UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Teachers Insurance and Annuity Association of America/Nuveen Asset Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trus...
-
NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke
DALLAS--(BUSINESS WIRE)--NeuWire Medical today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the ReWire Vagus Nerve Stimulation System in patients with chronic ischemic stroke and upper-limb dysfunction. The prospective, multicenter, randomized, sham-controlled study will enroll up to 135 participants across up to 12 U.S. clinical sites. Study initiation is expected in t...
-
Harlem Globetrotters: Rivalry Tour Tips Off December 18 – Unveiling Two New Rival Teams That Will Also Take on the Legendary Team Across 350+ Games Around the Globe
ATLANTA--(BUSINESS WIRE)--The award-winning, Guinness World Record holding, Naismith Hall of Fame member, Harlem Globetrotters, begin their second century of excellence with the Harlem Globetrotters: Rivalry Tour, kicking off on Friday, December 18 and extending across 200+ domestic markets and over 150+ international markets around the globe. The all-new game expands the Harlem Globetrotters universe with two new rival teams joining the Washington Generals, bringing new competition and new cha...
-
Juicebox and Newmark Show Software and Tech Dominate Talent Searches in San Francisco, With Office Leasing Tracking Toward 30-Year High
SAN FRANCISCO--(BUSINESS WIRE)--Juicebox, the AI recruiting platform, today announced the release of SF Is So Back, a new report examining the talent companies searched for and, in collaboration with Newmark Research, the office space they committed to during the first half of 2026.San Francisco could be reclaiming its place at the center of tech. In 2026, the data tells a compelling story, with hiring demand extending across business functions and companies making larger, longer-term commitment...
-
Science Corp. Announces Long-Term (36 Months) Results of PRIMA BCI Clinical Trial Showing Durable Vision Restoration in Blind Patients Suffering from Geographic Atrophy
ALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced long-term (36 months) followup data from its pivotal PRIMAvera clinical trial (NCT04676854). The results were presented in a late-breaking session at the 26th EURETINA Congress of European retina specialists in Vienna by Mahi Muqit, MD, PhD, Consultant Vitreoretinal Surgeon at Moorfields Eye Hospital NHS Foundation Trust and Associate Professor at the Institu...
-
Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3 Permanent TSB Group Holdings plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Fund(s) for whom Sand Grove Capital Management LLP is the Investment Manager Company dealt in Permanent TSB Group Holdings plc Class of relevant security to which the dealings being disclosed relate (Note 2) €0.01 ord...
-
24th Annual MIT Sloan CFO Summit Features “The Human CFO: Creativity and Judgment” With AT&T, Chevron, Target, Snowflake, and Southwest Airlines
CAMBRIDGE, Mass.--(BUSINESS WIRE)--The MIT Sloan CFO Summit, the nation’s preeminent one-day CFO conference, celebrates its 24th anniversary of keynote speakers, panel discussions, on-topic conversations, and the opportunity to network and learn with best-in-class leaders. To be held Thursday, November 19, 2026, the event attracts 400+ CFOs and senior financial executives from a broad mix of business and sectors. This year’s theme, The Human CFO: Creativity and Judgment, acknowledges the missio...
-
Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3 Rotork plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...